Dr. Maggiore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Elevance Health - Headquarters
220 Virginia Ave
Indianapolis, IN 46204- Is this information wrong?
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 2011 - 2013
- University of ChicagoFellowship, Geriatric Medicine (Internal Medicine), 2010 - 2011
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 2004 - 2007
- University of Illinois College of MedicineClass of 2004
Certifications & Licensure
- WI State Medical License 2005 - 2025
- MI State Medical License 2022 - 2025
- NY State Medical License 2016 - 2025
- OR State Medical License 2013 - 2021
- IL State Medical License 2010 - 2014
- CT State Medical License 2007 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Geriatric Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsPolypharmacy in older adults with cancer undergoing radiotherapy: A review.Jennifer Novak, Annette Goldberg, Kavita Dharmarajan, Arya Amini, Ronald J Maggiore, Carolyn J Presley, Ginah Nightingale> ;Journal of Geriatric Oncology. 2022 Jul 1
- 14 citationsThe longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy.Nikesha Gilmore, Supriya G. Mohile, Lianlian Lei, Eva Culakova, Mostafa R. Mohamed, Allison Magnuson, Kah Poh Loh, Ronald J. Maggiore, Elizabeth Belcher, Alison Conlin...> ;Breast Cancer Research. 2021 Feb 5
- 8 citationsPalbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial.Peter Oppelt, Jessica Ley, Francis P. Worden, Kevin Palka, Ronald J. Maggiore, Jingxia Liu, Douglas Adkins> ;Oral Oncology. 2021 Mar 1
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: